DAVID DINGLI, M.D.
Osteopathic Medicine at 1 St, Rochester, MN

License number

Minnesota 41605

Organization information

See more information about DAVID DINGLI at bizstanding.com

David Dingli MD,PHD

200 1 St SW, Rochester, MN 55905

Industry:

Internist

Phone:

(800) 660-4582 (Phone)

David J. Dingli

Professional information

Dr. David J Dingli, Rochester MN - MD (Doctor of Medicine)

Specialties:

Hematology

Address:

Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)

Certifications:

Hematology, 2005, Internal Medicine, 2000

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
University Of Malta, Faculty Of Medicine and Surgery
Graduated: 1992
St Luke's Hospital
Graduated: 1994
Mayo Grad School Med
Graduated: 2005
Graduated: 1996
West Glasgow University Hosps/Nhs
Graduated: 1997

Professor Of Medicine And Hematology At Mayo Clinic

Position:

Professor of Medicine at Mayo Clinic

Location:

Rochester, Minnesota Area

Industry:

Hospital & Health Care

Work:

Mayo Clinic since Aug 2007 - Professor of Medicine

Education:

Harvard University 2005 - 2007
Mayo Clinic 2003 - 2005
Mayo Graduate School 2000 - 2003
Doctor of Philosophy (PhD), Molecular Biology Mayo Clinic 1997 - 2000
L-Università ta' Malta 1987 - 1992

Skills:

Medicine, Molecular Biology, Cancer, Translational Research, Science, Oncology, Computational Biology, Internal Medicine, Cancer Research, Clinical Trials, Animal Models, Cell Culture, Medical Education, Stem Cell Transplant, Gene Therapy, Flow Cytometry, Medical Research, Molecular Imaging, Translational Medicine, Clinical Research, Hospitals, Genetics, Healthcare

David Dingli, Rochester MN

Specialties:

Internist

Address:

200 1St St Sw, Rochester, MN 55905

Education:

University of Malta, Faculty of Medicine and Surgery - Doctor of Medicine
Mayo Clinic College of Medicine - Doctor of Philosophy

Board certifications:

American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)

Erythropoietic Stimulating Agent (Esa) Dosage Determination

US Patent:

2013019, Jul 25, 2013

Filed:

Jan 4, 2011

Appl. No.:

13/519843

Inventors:

Craig L. Hocum - Winona MN, US
James T. McCarthy - Rochester MN, US
David P. Steensma - Wellesley MA, US
David Dingli - Rochester MN, US
James L. Rogers - Rochester MN, US
Edward J. Gallaher - Hillsboro OR, US

Assignee:

MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN

International Classification:

G06F 19/12

US Classification:

703 11

Abstract:

An Erythropoietic Stimulating Agent (ESA) dosing system/method determines patient-specific ESA therapies for patients affected by insufficient hemoglobin production that may benefit from ESA treatment. The ESA dosing system includes a model that represents a process by which red blood cells are produced in humans. The model may include one or more parameters, the values of which are patient-specific. The model takes into account patient-specific historical hemoglobin (Hgb) data and corresponding historical ESA dosage data to estimate the patient-specific values of the model parameters, and determines a target therapeutic dose of the ESA that may maintain the patient's Hgb within a target range.